According to IMARC Group’s latest report, titled “Remote Patient Monitoring Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” Offers a comprehensive analysis of the industry, which comprises insights on remote patient monitoring market
size reached US$ 1.3 Billion in 2022. The global remote patient monitoring (RPM) represents a subset of telehealth that utilizes digital technologies to collect medical and other forms of data regarding the patient outside the healthcare setting. This information generally comprises blood pressure, blood sugar, weight, blood oxygen levels, heart rate, and electrocardiograms, which are transmitted to medical providers using a telehealth computer system and software that can be installed on a smartphone, computer, and tablet. RPM aids healthcare professionals in monitoring the condition and improving the quality of care given to patients from anywhere across the globe. As a result, this technique finds widespread applications in hospitals, homecare settings, and clinics.
The escalating demand for this technique by healthcare providers across countries to observe patients with mild symptoms and provide hospital-based care on a timely basis, on account of the sudden outbreak of the COVID-19 pandemic, is among the primary factors driving the remote patient monitoring market. Besides this, the elevating prevalence of cardiovascular diseases and the rising geriatric population, which is more susceptible to chronic conditions, are further augmenting the market growth. Moreover, the development of RPM by the leading players that allows real-time video interaction between the patient and the healthcare provider, and the introduction of innovative variants are also catalyzing the global market. Apart from this, the expanding healthcare infrastructure, various advancements in wireless technologies, and the increasing penetration of smartphones are shifting medical services from clinic-centric to patient-centric delivery models, which are acting as significant growth-inducing factors. Furthermore, the launch of the G6 CGM device, a small sensor for measuring glucose levels and sending the data wirelessly to a display device through a transmitter, is anticipated to propel the remote patient monitoring market over the forecasted period. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2028, exhibiting a growth rate (CAGR) of 15.4% during 2023-2028.
Ask Analyst and Browse Full Report with TOC & List of Figure:
List of Key Companies Covered in this Market Report:
Abbott Laboratories (NYSE: ABT)
AMD Global Telemedicine Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation (NYSE: BSX)
Dexcom, Inc. (NASDAQ: DXCM)
GE Healthcare Inc. (Danaher Corporation) (NYSE: GE)
Honeywell International Inc. (NYSE: HON)
Koninklijke Philips N.V. (AMS: PHIA)
Medtronic Inc. (NYSE: MDT)
Nihon Kohden Corporation (TYO: 6849)
OSI Systems Inc. (NASDAQ: OSIS)
Roche Holding AG (SWX: RO)
The report has segmented the market on the basis of device type, application, end-use and geography.
Breakup by Device Type:
Blood Pressure Monitor
Heart Rate Monitor
Breakup by Application:
Cardiovascular Diseases Treatment and Monitoring
Sleep Disorder Treatment
Weight Management and Fitness Monitoring
Breakup by End-Use:
Hospitals and Clinics
Breakup by Geography:
North America (U.S. & Canada)
Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
Latin America (Brazil, Mexico)
Middle East & Africa
Key highlights of the report:
Market Performance (2017-2022)
Market Outlook (2023- 2028)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Want to print your doc? This is not the way.
Try clicking the ⋯ next to your doc name or using a keyboard shortcut (